DelveInsight’s analysts estimate that the sarcoidosis market is expected to show positive growth, mainly attributed to increased prevalence and the expected launch of novel therapies during the forecast period (2023–2032) LAS VEGAS, Nov. 2, 2023 /PRNewswire/ — DelveInsight’s Sarcoidosis…